Is Gwph A Good Buy 〈HD〉

: Jazz combined its existing focus on sleep disorders and oncology with GW's cannabinoid platform.

GW Pharmaceuticals () is no longer available for purchase as an independent stock. It was acquired by Jazz Pharmaceuticals (Nasdaq: JAZZ ) on May 5, 2021, for approximately $7.2 billion. Acquisition Details is gwph a good buy

If you are interested in the assets formerly owned by GW Pharmaceuticals, you must now look at . To determine if JAZZ is a "good buy," consider the following factors derived from the merger: : Jazz combined its existing focus on sleep

: Shareholders of GWPH American Depositary Shares (ADS) received $200 in cash and $20 in Jazz ordinary shares for each ADS held. Acquisition Details If you are interested in the

: The acquisition was driven largely by GW's blockbuster cannabis-derived drug, Epidiolex , which treats rare forms of childhood epilepsy. How to Invest Now

: Following the completion of the merger, GWPH was delisted from the Nasdaq.